SCHEMBL26697258

SCHEMBL26697258

COc1cc2c(Oc3ccc(NC(=O)Nc4cccc(F)c4)c(Cl)c3)ncnc2cc1O

nearest known ligand 0.72

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
KDR P35968 15/20 0.72
FLT1 P17948 4/20 0.71
FLT4 P35916 4/20 0.71
BRAF P15056 6/20 0.63
RAF1 P04049 4/20 0.63
KIT P10721 1/20 0.60
PDGFRA P16234 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26697275 0.91 KDR (0.68) KDRFLT1FLT4BRAFRAF1
SCHEMBL26697330 0.91 KDR (0.73) KDRFLT1FLT4BRAFRAF1
SCHEMBL26894874 0.90 BRAF (0.74) KDRFLT1FLT4BRAFRAF1
SCHEMBL26697249 0.89 KDR (0.72) KDRFLT1FLT4BRAFRAF1
SCHEMBL26894919 0.88 KDR (0.71) KDRFLT1FLT4BRAFRAF1
SCHEMBL26697268 0.87 KDR (0.70) KDRFLT1FLT4BRAFRAF1
SCHEMBL26697206 0.86 KDR (0.70) KDRFLT1FLT4BRAFKIT
SCHEMBL26697297 0.86 KDR (0.69) KDRFLT1FLT4KITPDGFRA
SCHEMBL26697251 0.86 KDR (0.70) KDRFLT1FLT4BRAFKIT
SCHEMBL26894876 0.85 KDR (0.68) KDRFLT1FLT4BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114920703-B Quinazoline derivative and preparation method and application thereof 天津济坤医药科技有限公司 2024-01-09 CN disclosed
WO-2023226323-A1 QUINAZOLINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 天津济坤医药科技有限公司 2023-11-30 WO disclosed
WO-2023226323-A1 QUINAZOLINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 天津济坤医药科技有限公司 2023-11-30 WO disclosed
CN-114920703-A Quinazoline derivative and preparation method and application thereof 天津济坤医药科技有限公司 2022-08-19 CN disclosed